BACKGROUND
FOCUS AREAS
A dedicated biologist and regulatory affairs professional responsible for managing biologics and small molecule projects at various stages of clinical development, from early to late phases.
Client operations
Regulatory affairs/operations
Project management
Guangyuan (Claire) Li is a Senior Regulatory Project Manager at ELIQUENT Life Science. She manages biologics and small molecule projects at various stages of clinical development, from early to late phases. Her role includes managing project timelines, serving as the primary point of contact for coordinating and communicating with internal subject matter experts and external stakeholders as well as health authorities, and providing regulatory guidance to support eCTD submissions.
In Guangyuan’s current position as a senior regulatory project manager, she has managed and contributed to more than 10 Investigational New Drug (IND) Applications and a variety of other regulatory submissions. These include Breakthrough Designation Request (BTDR), Fast Track Designation, Orphan Drug Designation (ODD) Request, Initial and Agreed Pediatric Study Plans (iPSP), INTERACT meeting request/meeting package, pre-IND/end of phase (EOP)/Type D meeting request/meeting package.
Before joining ELIQUENT, Guangyuan was a Project Manager at Wuxi Biologics and was an ORISE postdoctoral fellow at the Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA.
-
EDUCATION:
Ph.D. in Zoology and Physiology, University of Wyoming
Bachelor of Science in Physiology, University of Wyoming
Bachelor of Science in Biological Technology, Shanghai Normal UniversityCERTIFICATIONS:
Regulatory Affairs Certification(RAC) Drugs, Regulatory Affairs Professionals Society -
PROFESSIONAL EXPERIENCE:
WuXi Biologics Project Manager
Postdoctoral fellow (ORISE)-Center for Drug Evaluation and Research, U.S. FDA
Postdoctoral fellow-University of California, San DiegoAREAS OF EXPERTISE:
Regulatory affairs/operations
Project management
Molecular biology skills
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves.
Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.